Article
03 Nov 2021
FDA's Long-Awaited De Novo Classification Rule Is Finally Here
AUTHORS CONTENT
Article
05 Apr 2018
FDA Delays EMDR System Adverse Event Codes Update
Article
26 Jan 2018
Moratorium On Medical Device Excise Tax Extended For Two Years
Article
25 Jan 2018
What Pharma Companies Need To Know About FDA's New Draft IVD Guidance
Article
21 Aug 2017
FDA Announces Digital Health Innovation Action Plan To Implement 21st Century Cures Act
Article
09 Jun 2017
California Bill May Upend Pharma Company Interaction With HCPs
Article
10 May 2017
OCR Announces First HIPAA Settlement With Wireless Health Services Provider
Article
27 Feb 2017
FDA Devices Center Issues Multiple Guidances In The Obama Administration's Final Months
Article
13 Jan 2017
FDA Issues Final Guidance On Postmarket Cybersecurity
Article
03 Jan 2017
FDA Issues Final Guidance On "Emerging Signals"
Article
15 Dec 2016
21st Century Cures Act And Its Effect On Digital Health
Article
15 Dec 2016
21st Century Cures Act And Medical Device Regulatory Pathways
Article
17 Nov 2016
Top Takeaways From FDA Draft Guidance On Software As A Medical Device
Article
10 Oct 2016
10 Key Takeaways From FDA's Draft Guidance On 510(K) Modifications
Article
06 Sep 2016
FDA Uses Summer To Issue Numerous Device Guidance Documents
Article
04 Aug 2016
FDA Issues Final Guidance For General Wellness Devices
Article
08 Feb 2016
FDA Issues New Draft Guidance On Postmarket Cybersecurity For Medical Devices
Article
05 Nov 2014
Medical Device Update: Distinguishing Medical Device Recalls From Medical Device Enhancements
Article
03 Sep 2014
Medical Device Update: FDA Issues Draft Guidance On Streamlined De Novo Classification Process
Article
11 Aug 2014
FDA Issues Final Guidance On 510(k) Determinations, Use Of "Split" Predicates Strongly Discouraged